Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2010, Issue , 2010, Pages 368-376

  Suttorp, Meinolf ^a   Millot, Frédéric ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

CHILD; CHRONIC MYELOID LEUKEMIA; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; HUMAN; METABOLISM; RECURRENT DISEASE; REVIEW; STEM CELL TRANSPLANTATION;

CHILD; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RECURRENCE; STEM CELL TRANSPLANTATION;

EID: 79955040838     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2010.1.368     Document Type: Review

References (0)